These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 23488524)

  • 41. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 42. Hormone replacement therapy in postmenopausal women.
    Prelevic GM; Kocjan T; Markou A
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hormone replacement therapy: controversies, pros and cons.
    Warren MP; Halpert S
    Best Pract Res Clin Endocrinol Metab; 2004 Sep; 18(3):317-32. PubMed ID: 15261840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Menopausal hormone therapy (MHT): refining our understanding of MHT research, optimally applying results, and considering the future of MHT.
    Anagnostis EA
    J Pharm Pract; 2012 Jun; 25(3):324-30. PubMed ID: 22550160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes.
    Harman SM; Vittinghoff E; Brinton EA; Budoff MJ; Cedars MI; Lobo RA; Merriam GR; Miller VM; Naftolin F; Pal L; Santoro N; Taylor HS; Black DM
    Am J Med; 2011 Mar; 124(3):199-205. PubMed ID: 21396500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Summaries for patients. Postmenopausal hormone replacement therapy to prevent chronic conditions: recommendations from the U.S. Preventive Services Task Force.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2002 Nov; 137(10):I48. PubMed ID: 12435233
    [No Abstract]   [Full Text] [Related]  

  • 47. Menopause: estrogen replacement, osteoporosis, and serum lipoproteins.
    Gnatuk CL; Ory SJ
    Curr Opin Obstet Gynecol; 1989 Dec; 1(2):187-94. PubMed ID: 2491121
    [No Abstract]   [Full Text] [Related]  

  • 48. [Hormone replacement therapy for menopausal women].
    Nozaki M
    Fukuoka Igaku Zasshi; 2000 Mar; 91(3):74-9. PubMed ID: 10917758
    [No Abstract]   [Full Text] [Related]  

  • 49. Drug delivery systems for hormone therapy.
    Yoo JW; Lee CH
    J Control Release; 2006 May; 112(1):1-14. PubMed ID: 16530874
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postmenopausal hormone therapy: from monkey glands to transdermal patches.
    Davis SR; Dinatale I; Rivera-Woll L; Davison S
    J Endocrinol; 2005 May; 185(2):207-22. PubMed ID: 15845914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is there a case for targeting hormone replacement therapy for osteoporosis at the menopause?
    Stevenson JC
    Osteoporos Int; 1998; 8 Suppl 1():S47-50. PubMed ID: 9682798
    [No Abstract]   [Full Text] [Related]  

  • 52. Prevention and treatment of osteoporosis with hormone replacement therapy.
    Christiansen C
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():45-54. PubMed ID: 8499959
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
    Grant EC
    J Natl Cancer Inst; 2011 Jul; 103(13):1069; reply 1069-70. PubMed ID: 21700925
    [No Abstract]   [Full Text] [Related]  

  • 54. Postmenopausal estrogens--opposed, unopposed, or none of the above.
    Willett WC; Colditz G; Stampfer M
    JAMA; 2000 Jan; 283(4):534-5. PubMed ID: 10659883
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment of menopausal symptoms--review of the current literature].
    Magyar Z; Fél T
    Orv Hetil; 2006 May; 147(19):879-85. PubMed ID: 16784143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: consensus opinion of The North American Menopause Society.
    Menopause; 2000; 7(2):87-95. PubMed ID: 10746890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Estrogen progestogen replacement therapy for hyperlipidemia in postmenopausal women].
    Hayakawa A
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():701-6. PubMed ID: 11347158
    [No Abstract]   [Full Text] [Related]  

  • 58. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
    Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polish consensus: procedure in case of estrogen deficiency in women after breast cancer therapy.
    Milewicz A; Szymański W; Ruzyłło W; Zgliczyński S; Reinfus M; Zieliński J; Debski R; Demissie M; Tworowska U
    Gynecol Endocrinol; 2002 Oct; 16(5):385-9. PubMed ID: 12587533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.